Moleculin Biotech
Seite 17 von 33 Neuester Beitrag: 25.04.21 03:16 | ||||
Eröffnet am: | 17.11.16 18:08 | von: Balu4u | Anzahl Beiträge: | 802 |
Neuester Beitrag: | 25.04.21 03:16 | von: Sabrinamfvb. | Leser gesamt: | 212.041 |
Forum: | Hot-Stocks | Leser heute: | 37 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 14 | 15 | 16 | | 18 | 19 | 20 | ... 33 > |
Wenn man das Thema angeht, muss man sehr schnell sein, ansonsten ist es verbranntes Geld!
https://www.wallstreet-online.de/diskussion/...float#beitrag_63344083
Gamechanger?
HOUSTON, April 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, announced that Walter Klemp, Chairman and Chief Executive Officer, will host a web-based conference call on April 16th at 4:30pm ET to explain the significance of the recent discovery that the active compound in WP1122 has been shown to reduce replication of SARS-CoV-2 by 100%.
https://finance.yahoo.com/news/...stor-conference-call-113000351.html